Biotech

Theralase Technologies announced it began trading on the OTCQX, following an upgrade from the OTC Pink.

Theralase Technologies (TSXV:TLT) announced it began trading on the OTCQX, following an upgrade from the OTC Pink.
As quoted in the press release:

Effective immediately, Theralase has been upgraded to commence trading on the OTCQX market from the Pink® market under the symbol “TLTFF.”
“Trading on the OTCQX will allow Theralase to build visibility and provide a more transparent market for U.S. investors,” said Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group. “We are pleased to welcome Theralase to OTCQX and look forward to supporting the company and its shareholders in the public markets.”
Roger Dumoulin-White, President and CEO of Theralase, stated that, “We are delighted to have qualified for trading on OTCQX by meeting high financial standards, following best practice corporate governance guidelines, demonstrating compliance with U.S. securities laws and having a professional third-party sponsor introduction. All of these key characteristics of our Company will provide security and transparency for U.S. based investors that elect to trade in our stock.”

Click here to read the full press release.

Featured

MARKETS

Markets
TSX20532.18+148.43
TSXV714.66+12.92
DOW32637.19+516.91
S&P 5004057.84+79.11
NASD11740.65+305.91
ASX7105.90-49.30

COMMODITIES

Commodities
Gold1854.81+1.75
Silver22.10+0.08
Copper4.29+0.03
Palladium2025.50+17.50
Platinum955.00+6.00
Oil114.23+0.14
Heating Oil3.86+0.01
Natural Gas8.85-0.04

DOWNLOAD FREE REPORTS

×